Related Experiment Video
Updated: May 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Gender disparities in optimal lipid control among patients with coronary artery disease
Chun-Yen Chen1, Shao-Yuan Chuang, Ching-Chang Fang
1Cardiovascular Division, Department of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College.
Insights
Coronary heart disease (CHD) affects both genders, with hypercholesterolemia being a key risk factor. This review explores gender disparities in lipid management to improve treatment outcomes for all patients.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Coronary heart disease (CHD) is a leading global cause of mortality.
- Hypercholesterolemia is a significant risk factor for CHD development.
- Statins are proven effective for CHD prevention, with some evidence suggesting equal or greater efficacy in women.
Purpose of the Study:
- To explain gender differences in lipid control among individuals with or at risk of CHD.
- To raise awareness of gender disparities in lipid management.
- To identify strategies for narrowing these disparities.
Main Methods:
- Review of existing literature on lipid management and gender differences in CHD.
- Analysis of observational studies reporting on lipid goal attainment.
- Synthesis of evidence regarding statin efficacy in men versus women.
Main Results:
- Observational studies indicate a significant gender gap in achieving lipid goals according to primary care guidelines.
- Despite potential equal or greater statin effectiveness in women, they experience disparities in lipid control.
- Understanding these differences is crucial for effective CHD prevention.
Conclusions:
- Gender disparities in lipid management for CHD persist.
- Further research and targeted interventions are needed to address these gaps.
- Improving lipid control in women is essential for reducing CHD mortality.
Abstract:
Coronary heart disease(CHD) is the leading cause of death worldwide in both men and women. Hypercholesterolemia is a major factor contributing to the incidence of CHD. Many lipid-lowering trials have shown statins to be effective medications for the primary and secondary prevention of CHD. Some studies have suggested that statins are as or more effective in women than in men. However, there is a substantial gender gap in lipid goal attainment with respect to primary care guidelines, as reported in observational studies. In this article, we attempt to explain gender differences in lipid control in individuals with or at risk of CHD in order to improve awareness of and narrow gaps in gender disparities in lipid management.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
